Clinical Trials Directory

Trials / Unknown

UnknownNCT03024788

Determination of the Optimum Cut-off Value of Type 2 Diabetes Diagnosis Among Chinese Population(SENSIBLE STUDY II)

Determination of Cut-off Value of Advanced Glycation End-product and Glycosylated Haemoglobin in Type 2 Diabetes Diagnosis in China

Status
Unknown
Phase
Study type
Observational
Enrollment
6,000 (actual)
Sponsor
Zhongda Hospital · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

Study of the correlation between AGEsP and HbA1c and diabetic retinopathy prevalence: determination of cut-off value of AGEsP and HbA1c in type 2 diabetes diagnosis in China

Detailed description

To find the cut-off point of AGEsP and HbA1c for diagnosis of diabetes by drawing the logistic regression model between prevalence of retinopathy and AGEsP level and HbA1c level,and find the point where the prevalence of retinopathy changes most rapidly.

Conditions

Interventions

TypeNameDescription
DEVICEsyringe, fundus camera etcPhysical examination, fundus examination, blood and urine samples collection

Timeline

Start date
2017-01-01
Primary completion
2020-06-01
Completion
2020-12-01
First posted
2017-01-19
Last updated
2017-05-08

Source: ClinicalTrials.gov record NCT03024788. Inclusion in this directory is not an endorsement.